Categories
-
Controls for NAT methods
Controls for NAT methods -
Linearity panels for viral load assays
Linearity panels for viral load assays -
Multiple viral genotype reference panels for viral nat assays
Multiple viral genotype reference panels for viral nat assays -
Non-enveloped virus standard dilution panels
Non-enveloped virus standard dilution panels -
Nucleic Acid Sensitivity Panels
Nucleic Acid Sensitivity Panels -
Run Controls for Nucleic Acid Testing
Run Controls for Nucleic Acid Testing -
SARS standard dilution panels
SARS standard dilution panels -
Seroconversion
Seroconversion -
Serology
Serology -
Validation-Verification
Validation-Verification -
Viraq quant controls for viral load assays
Viraq quant controls for viral load assays -
West Nile reference panels
West Nile reference panels
Quality Control Panels
Performing a quality control is the best way to ensure accurate test results, so using our range of QUALITY CONTROL PANELS provides a benefit to both your patients and the reputation of your laboratory.
We can offer you a wide choice of panels that can challenge the sensitivity, specificity and working range of your assays or be used for diagnostic development or batch release in manufacturing. Panels include representative data from current assays on the market.
Our range of VERIFICATION / VALIDATION Panels are designed to use with assays to determine the presence of antigen, antibody RNA or DNA based upon the intended use of the panel.
We also have an extensive range of SEROCONVERSION PANELS for detection of asymptomatic donors infected with HIV, HCV, HBV and EBV, as well as SURVEILLANCE PANELS and LONGITUDINAL PANELS.
Our panels are run on as many different diagnostic kits as possible to measure relevant markers of seroconversion.
All testing is performed by Certified Reference Laboratories and Domestic and International Regulatory Bodies.
Our range of SEROLOGICAL CONTROLS, the SeraCon Run Controls, are intended for use in assessing the performance of immunoassay test procedures for the qualitative determination of HBsAg, anti-HIV and anti-HCV.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|